Dow Up0.26% Nasdaq Down1.07%

More On MBI.V

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Med BioGene Inc. (MBI.V)

-TSXV
0.08 0.00(0.00%) Sep 15
ProfileGet Profile for:
Med BioGene Inc.
580 Hornby Street
Suite 510
Vancouver, BC V6C 3B6
Canada - Map
Phone: 800-641-3593
Fax: 888-646-2531
Website: http://www.medbiogene.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:N/A

Business Summary 

Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient’s tumor to provide information to assist in tailoring treatment for that specific patient. The company has a collaboration agreement with the University Health Network. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Med BioGene Inc.

Key Executives 
 PayExercised
Mr. Iain Weir-Jones ,
Chairman and Chief Exec. Officer
N/AN/A
Ibrahim Ghobrial ,
Chief Financial Officer
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.